PMID- 32743055
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2364-3722 (Print)
IS  - 2196-9736 (Electronic)
IS  - 2196-9736 (Linking)
VI  - 8
IP  - 8
DP  - 2020 Aug
TI  - Endoscopic ultrasound-guided hepaticogastrostomy or hepaticojejunostomy without 
      dilation using a stent with a thinner delivery system.
PG  - E1034-E1038
LID - 10.1055/a-1169-3749 [doi]
AB  - Background and study aim  Use of endoscopic ultrasound-guided biliary drainage 
      (EUS-BD) has recently increased. In EUS-BD, after puncturing the bile duct, 
      dilation is performed and the stent is deployed. Due to adverse events (AEs) such 
      as unexpected displacement of the guidewire, simplified procedures are required. 
      Currently, stents with small-diameter delivery systems are being rapidly 
      developed, expanding the possibilities for of EUS-BD without dilation. In this 
      retrospective study, we aimed to evaluate the success rates and AEs in patients 
      who underwent EUS-guided hepaticogastrostomy (EUS-HGS) or EUS-guided 
      hepaticojejunostomy (EUS-HJS) without dilation. Patients and methods  Six 
      consecutive patients with malignant biliary obstruction and failed transpapillary 
      BD underwent EUS-HGS or EUS-HJS without dilation, deploying a 6-mm fully-covered 
      self-expandable metallic stent with a 6-Fr delivery system. Results  The 
      technical and clinical success rates were 100 %. There was one case each of stent 
      migration and stent occlusion, and no other AEs were noted. Conclusions  EUS-HGS 
      or EUS-HJS without dilation using a stent with a 6-Fr delivery system had high 
      technical and clinical success rates; however, additional cases are required to 
      validate the study findings.
FAU - Maehara, Kosuke
AU  - Maehara K
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Hijioka, Susumu
AU  - Hijioka S
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Nagashio, Yoshikuni
AU  - Nagashio Y
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Ohba, Akihiro
AU  - Ohba A
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Maruki, Yuta
AU  - Maruki Y
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Suzuki, Hiromi
AU  - Suzuki H
AD  - Department of Radiological Technology, National Cancer Center Hospital, Tokyo, 
      Japan.
FAU - Sone, Miyuki
AU  - Sone M
AD  - Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, 
      Japan.
FAU - Okusaka, Takuji
AU  - Okusaka T
AD  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center 
      Hospital, Tokyo, Japan.
FAU - Saito, Yutaka
AU  - Saito Y
AD  - Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
LA  - eng
PT  - Journal Article
DEP - 20200721
PL  - Germany
TA  - Endosc Int Open
JT  - Endoscopy international open
JID - 101639919
PMC - PMC7373653
COIS- Competing interests The authors declare that they have no conflict of interest.
EDAT- 2020/08/04 06:00
MHDA- 2020/08/04 06:01
PMCR- 2020/08/01
CRDT- 2020/08/04 06:00
PHST- 2020/01/25 00:00 [received]
PHST- 2020/04/09 00:00 [accepted]
PHST- 2020/08/04 06:00 [entrez]
PHST- 2020/08/04 06:00 [pubmed]
PHST- 2020/08/04 06:01 [medline]
PHST- 2020/08/01 00:00 [pmc-release]
AID - 10.1055/a-1169-3749 [doi]
PST - ppublish
SO  - Endosc Int Open. 2020 Aug;8(8):E1034-E1038. doi: 10.1055/a-1169-3749. Epub 2020 
      Jul 21.